These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29025920)

  • 1. Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Rahimi K; Otto CM
    Heart; 2017 Nov; 103(21):1653-1655. PubMed ID: 29025920
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Matuleviciene-Anängen V; Rosengren A; Svensson AM; Pivodic A; Gudbjörnsdottir S; Wedel H; Kosiborod M; Haraldsson B; Lind M
    Heart; 2017 Nov; 103(21):1687-1695. PubMed ID: 28710186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 4. Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?
    Nathan DM
    Diabetes Care; 1995 Feb; 18(2):251-7. PubMed ID: 7729307
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
    Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
    Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updating the insulin lispro file.
    Grossman LD
    CMAJ; 1998 May; 158(9):1132-3. PubMed ID: 9597962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intensive blood glucose reduction: yes or no?].
    Bischoff A
    MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 9. Will the use of insulin analogs improve glycemic control during adolescence?
    Dunger DB
    Pediatr Diabetes; 2003 Jun; 4(2):61-3. PubMed ID: 14655260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 11. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between diabetes, level of glycaemic control and eye infection: Cohort database study.
    Ansari AS; de Lusignan S; Hinton W; Munro N; McGovern A
    Prim Care Diabetes; 2017 Oct; 11(5):421-429. PubMed ID: 28648963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.
    Costacou T; Evans RW; Orchard TJ
    Diabet Med; 2016 Nov; 33(11):1524-1527. PubMed ID: 27028131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on the decay of glycated hemoglobin HbA1c in diabetic patients.
    Rech ME
    Exp Clin Endocrinol Diabetes; 1996; 104(2):102-5. PubMed ID: 8740932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.
    Van Name MA; Miller KM; Commissariat PV; Whitehouse AL; Harrington KR; Anderson BJ; Mantravadi MG; Levy W; DeSalvo DJ; Tamborlane WV; Hilliard ME; Laffel LM; DiMeglio LA
    Diabet Med; 2019 Nov; 36(11):1508-1510. PubMed ID: 31295359
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
    Becker RH; Frick AD; Nosek L; Heinemann L; Rave K
    Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.